Columvi Concentrate
Product Images NDC 50242-127

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Columvi (NDC 50242-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 mg/10 mL Vial Carton)

Label of Columvi (glofitamab-gxbm) Injection 10 mg/10 mL concentrate for intravenous infusion. The label indicates a single-dose vial with instructions to discard unused portions and to dispense the enclosed Medication Guide. The product is labeled by Genentech, Inc.*

FDA Label Image

Principal Display Panel (2.5 mg/2.5 mL Vial Carton)

Label for Columvi (glofitamab-gxbm) Injection concentrate, 2.5 mg/2.5 mL (1 mg/mL) strength. The label indicates it is for intravenous infusion after dilution, single-dose vial, discard unused portion, and includes a note to dispense the enclosed Medication Guide. Labeled by Genentech, Inc., it shows one vial per package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.